Transforming Pharma Manufacturing Supply Chains Through AI and ERP Analytics

Abstract

The pharmaceutical manufacturing business has a complex, international supply chain, constrained by strict regulatory measures, rising costs, and growing pressure on product quality, supply, and efficacy. Conventional planning and control strategies have not been effective at managing demand volatility, equipment reliability, and inventory risk at a large scale. To this end, artificial intelligence and enterprise resource planning systems are emerging as transformative technologies that can revamp supply chain processes in pharmaceutical companies. The next stage of analytics in demand prediction, predictive maintenance, inventory optimization, and production planning is reachable due to the integration of AI and ERP solutions, increasing the efficiency of operations and improving decision-making quality. Based on empirical data by proven pharmaceutical manufacturers, up to 30% of forecast errors, 20-30% of unplanned unforeseen downtime, and ten to 20% of holding inventory costs are reduced after AI-facilitated adoption of ERP. Nevertheless, it has to be well run in data governance, inter-functional collaboration, and change management to facilitate the effective use of the technologies and ensure the reliability of the models, regulatory compliance, and workforce acceptance. This paper combines the empirical evidence base in the industry, practical case study applications, and analysis findings to deliberate on the feasibility of AI ERP integration in the pharmaceutical manufacturing process. It suggests an analytics-driven decision-making model with governance to make supply chains more resilient.